• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ADAM10 在人非小细胞肺癌中的过表达通过激活 Notch1 信号通路与细胞迁移和侵袭相关。

ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.

机构信息

Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, PR China.

出版信息

Oncol Rep. 2012 Nov;28(5):1709-18. doi: 10.3892/or.2012.2003. Epub 2012 Aug 30.

DOI:10.3892/or.2012.2003
PMID:22940701
Abstract

A disintegrin and metalloproteinase 10 (ADAM10) was identified as a key protease in the ectodomain shedding of various substrates, such as Notch1 protein, ErbB2 and E-cadherin, which are important in the development of non-small cell lung cancer (NSCLC). The aim of this study was to investi-gate the role of ADAM10 in NSCLC metastasis.We characterized the expression of ADAM10 and Notch1 in human NSCLC tissues in vivo. Immunohistochemical analysis indicated that ADAM10 expression was significantly increased in the NSCLC tissues, particularly in the metastatic tissues. Futhermore, ADAM10 overexpression positively correlated with Notch1 expression in the NSCLC tissues. The in vitro downregulation of ADAM10 expression using ADAM10 short hairpin RNA (shRNA) reduced the migration and invasion of NSCLC cells. We present further evidence that ADAM10 promotes NSCLC cell migration and invasion via the activation of the Notch1 signaling pathway. Taken together, our results suggest that ADAM10 may serve as a potential target for the therapeutic intervention of NSCLC metastasis. The data provided in this study may aid in the further understanding of the function of ADAM10 in the progression of NSCLC and open new perspectives for the diagnosis and treatment of NSCLC.

摘要

解整合素金属蛋白酶 10(ADAM10)被鉴定为各种底物的外显域脱落的关键蛋白酶,这些底物如 Notch1 蛋白、ErbB2 和 E-钙黏蛋白,在非小细胞肺癌(NSCLC)的发展中非常重要。本研究旨在研究 ADAM10 在 NSCLC 转移中的作用。我们在体内对人类 NSCLC 组织中 ADAM10 和 Notch1 的表达进行了表征。免疫组织化学分析表明,ADAM10 在 NSCLC 组织中表达显著增加,特别是在转移性组织中。此外,ADAM10 的过表达与 NSCLC 组织中 Notch1 的表达呈正相关。使用 ADAM10 短发夹 RNA(shRNA)下调 ADAM10 表达可减少 NSCLC 细胞的迁移和侵袭。我们提供了进一步的证据表明,ADAM10 通过激活 Notch1 信号通路促进 NSCLC 细胞的迁移和侵袭。综上所述,我们的研究结果表明,ADAM10 可能成为 NSCLC 转移治疗干预的潜在靶点。本研究提供的数据可能有助于进一步了解 ADAM10 在 NSCLC 进展中的功能,并为 NSCLC 的诊断和治疗开辟新的视角。

相似文献

1
ADAM10 overexpression in human non-small cell lung cancer correlates with cell migration and invasion through the activation of the Notch1 signaling pathway.ADAM10 在人非小细胞肺癌中的过表达通过激活 Notch1 信号通路与细胞迁移和侵袭相关。
Oncol Rep. 2012 Nov;28(5):1709-18. doi: 10.3892/or.2012.2003. Epub 2012 Aug 30.
2
ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.ADAM10 在人肝癌中过表达,并促进 HepG2 细胞的增殖、侵袭和迁移。
Oncol Rep. 2013 Oct;30(4):1715-22. doi: 10.3892/or.2013.2650. Epub 2013 Aug 2.
3
MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.微小RNA-140-5p通过靶向ADAM10介导的Notch1信号通路抑制下咽鳞状细胞癌的肿瘤细胞迁移和侵袭。
Exp Mol Pathol. 2016 Feb;100(1):132-8. doi: 10.1016/j.yexmp.2015.12.008. Epub 2015 Dec 15.
4
ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.ADAM10 在黑色素瘤转移中上调,与原发性黑色素瘤相比。
J Invest Dermatol. 2010 Mar;130(3):763-73. doi: 10.1038/jid.2009.335. Epub 2009 Oct 29.
5
RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo.RNA干扰介导的解整合素金属蛋白酶9基因沉默在体外和体内均可抑制非小细胞肺癌的肿瘤生长。
Mol Med Rep. 2015 Jul;12(1):1197-204. doi: 10.3892/mmr.2015.3477. Epub 2015 Mar 12.
6
Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.miR-140-5p 与 ADAM10 之间的相互作用抑制人舌癌细胞的迁移和侵袭。
Biochem Biophys Res Commun. 2014 Jun 6;448(3):308-14. doi: 10.1016/j.bbrc.2014.02.032. Epub 2014 Feb 13.
7
Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.通过弗林蛋白酶的转录调控实现Notch1自激活,弗林蛋白酶通过加工Notch1激活蛋白酶ADAM10和膜型1基质金属蛋白酶来维持Notch1信号传导。
Mol Cell Biol. 2015 Nov;35(21):3622-32. doi: 10.1128/MCB.00116-15. Epub 2015 Aug 17.
8
ADAM10: a new player in breast cancer progression?ADAM10:乳腺癌进展中的新角色?
Br J Cancer. 2015 Sep 15;113(6):945-51. doi: 10.1038/bjc.2015.288. Epub 2015 Aug 18.
9
Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.抗癌化疗通过下调肝细胞癌中ADAM10的表达来抑制MHC I类相关链a胞外域脱落。
Cancer Res. 2009 Oct 15;69(20):8050-7. doi: 10.1158/0008-5472.CAN-09-0789. Epub 2009 Oct 13.
10
Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.沉默ADAM10可抑制肝癌细胞的体外和体内生长。
Mol Med Rep. 2015 Jan;11(1):597-602. doi: 10.3892/mmr.2014.2652. Epub 2014 Oct 15.

引用本文的文献

1
ADAM Proteases in Cancer: Biological Roles, Therapeutic Challenges, and Emerging Opportunities.癌症中的ADAM蛋白酶:生物学作用、治疗挑战及新出现的机遇
Cancers (Basel). 2025 May 19;17(10):1703. doi: 10.3390/cancers17101703.
2
ADAM10 is a key player in the diagnosis, prognosis and metastasis of non-small cell lung cancer (NSCLC).ADAM10在非小细胞肺癌(NSCLC)的诊断、预后和转移中起着关键作用。
J Cancer. 2025 Feb 11;16(5):1736-1746. doi: 10.7150/jca.107236. eCollection 2025.
3
Unraveling the role of ADAMs in clinical heterogeneity and the immune microenvironment of hepatocellular carcinoma: insights from single-cell, spatial transcriptomics, and bulk RNA sequencing.
解析 ADAMs 在肝细胞癌临床异质性和免疫微环境中的作用:单细胞、空间转录组学和批量 RNA 测序的见解。
Front Immunol. 2024 Sep 13;15:1461424. doi: 10.3389/fimmu.2024.1461424. eCollection 2024.
4
Harnessing HEK293 cell-derived exosomes for hsa-miR-365a-3p delivery: Potential application in hepatocellular carcinoma therapy.利用源自人胚肾293细胞的外泌体递送hsa-miR-365a-3p:在肝细胞癌治疗中的潜在应用。
Heliyon. 2024 Apr 9;10(8):e29333. doi: 10.1016/j.heliyon.2024.e29333. eCollection 2024 Apr 30.
5
IL-12p40 Monomer: A Potential Player in Macrophage Regulation.白细胞介素-12 p40单体:巨噬细胞调节中的潜在参与者。
Immuno. 2024 Mar;4(1):77-90. doi: 10.3390/immuno4010005. Epub 2024 Feb 23.
6
Investigation of Biofilm-Associated Toxin as a Potential Squamous Cell Carcinoma Therapeutic.生物膜相关毒素作为鳞状细胞癌潜在治疗方法的研究。
Microorganisms. 2024 Jan 30;12(2):293. doi: 10.3390/microorganisms12020293.
7
Shifting the balance: soluble ADAM10 as a potential treatment for Alzheimer's disease.改变平衡:可溶性ADAM10作为阿尔茨海默病的潜在治疗方法。
Front Aging Neurosci. 2023 May 17;15:1171123. doi: 10.3389/fnagi.2023.1171123. eCollection 2023.
8
Lung microRNAs Expression in Lung Cancer and COPD: A Preliminary Study.肺癌和慢性阻塞性肺疾病中肺组织微小RNA的表达:一项初步研究
Biomedicines. 2023 Feb 28;11(3):736. doi: 10.3390/biomedicines11030736.
9
MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.微小RNA作为胃癌细胞中顺铂耐药性的关键调节因子。
Genes Environ. 2021 Jun 7;43(1):21. doi: 10.1186/s41021-021-00192-4.
10
A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation.一种用于预测Ⅰ/Ⅱ期非小细胞肺癌患者术后生存情况的高表达mRNA特征。
Sci Rep. 2021 Mar 12;11(1):5855. doi: 10.1038/s41598-021-85246-x.